Skip to textbook content
Doctor’s PassportTextbook
QuestionsFlashcardsBriefsDashboardAccount
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Multiple pregnancy and twin complications

Obstetrics and gynaecology · UK scope · Sources checked 7 Sept 2026 · Clinical review pending

RapidFull
!
Monochorionic twins with discordant fluid or deterioration

A marked difference in sac fluid, a missing donor bladder, abnormal Dopplers, hydrops or acute maternal distension may indicate a shared-placenta complication requiring fetal therapy assessment.

Action: Contact the tertiary fetal medicine service promptly, document gestation and consistent fetal labels, and provide each sac’s fluid, bladder, growth and Doppler findings; urgent maternal or fetal compromise requires immediate maternity assessment.

Synopsis

Use chorionicity and amnionicity to organise multiple-pregnancy care, recognise shared-placenta complications and plan surveillance, preterm prevention and birth for each fetus.

  • Determine chorionicity and amnionicity early; they guide risk and surveillance more directly than whether twins are genetically identical.
  • Use consistent fetal labels throughout every scan and report so measurements and interventions are attributed to the same fetus.
  • Monochorionic pregnancies need ultrasound surveillance every 14 days from 16 weeks for transfusion-related and growth complications.
  • Calculate weight discordance as the difference between larger and smaller estimated weight divided by the larger weight, multiplied by 100.
  • Increase surveillance for at least 20% discordance or any fetus below the tenth centile; at least 25% plus a fetus below the tenth warrants tertiary review.
  • For uncomplicated twins, offer planned birth at 37 weeks for DCDA, 36 weeks for MCDA and 32+0 to 33+6 weeks for MCMA.

Key red flags

A monochorionic donor sac DVP below 2 cm with recipient DVP above 8 cm before 20+0 weeks or above 10 cm from 20+0 weeks requires referral for suspected TTTS.

Rapid painful abdominal enlargement, breathlessness, reduced movements or preterm labour symptoms in a multiple pregnancy warrants immediate maternity review.

Single fetal death in a monochorionic pregnancy needs urgent specialist assessment of the survivor because shared vessels create additional neurological and circulatory risks.

Investigation priorities

01
Early ultrasound and persistent fetal labellingFirst step

Establish gestation, chorionicity, amnionicity and identity for repeated assessments.

Management branches

Structured antenatal careBuild a chorionicity-specific care plan

A twin or triplet pregnancy has been confirmed and requires an organised surveillance schedule.

  1. Assign a specialist maternity team, establish chorionicity and amnionicity and keep consistent fetal labels visible in all reports.
  2. Book scans appropriate to chorionicity, assess maternal anaemia and pre-eclampsia risks, and discuss cervical-length screening and preterm symptoms.
  3. Provide a provisional birth plan early enough for neonatal counselling, practical preparation and informed choices about route and place.

Key medicines

Vaginal progesterone for a short cervixOffer 200 mg vaginal capsules once daily at bedtime when a twin or triplet pregnancy has cervical length 25 mm or less; continue until 34 weeks or earlier birth.This use in twins and triplets is off-label; discuss the indication and preparation, and do not apply it universally to all multiple pregnancies.
Aspirin for qualifying pre-eclampsia riskPrescribe 75–150 mg orally daily from 12 weeks until birth when NICE risk assessment identifies one high-risk or more than one moderate-risk factor.Twins alone do not satisfy the multiple-moderate-factor rule; document additional risk, allergy and relevant bleeding concerns.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 7 Sept 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

  • NICE NG137 twin and triplet recommendations
  • NICE NG137 complete 2024 text in NCBI Bookshelf
  • RCOG monochorionic twin guidance 2024 partial update
  • ISUOG ultrasound in twin pregnancy 2025
  • NICE NG133 pre-eclampsia prevention

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom